CTOs on the Move


 
Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.dthera.com
  • 7310 Miramar Road Suite 350
    San Diego, CA USA 92126
  • Phone: 858.215.6360

Executives

Name Title Contact Details

Similar Companies

ACell

ACell, Inc. is a leading regenerative medicine company focused on the development, manufacturing, and commercialization of unique proprietary extracellular matrix (ECM) products to facilitate the repair and remodeling of damaged tissues. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology, offering superior healing options for doctors and patients. ACell is a privately held company and operates manufacturing facilities in Columbia, MD and Lafayette, IN.

Surgical Acuity Inc

Surgical Acuity Inc is a Middleton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mother Frances Hospital

Mother Frances Hospital is a Tyler, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Outfitters

Medical Outfitters is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sebacia

Sebacia is a clinical-stage` private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia’s goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia’s microparticles technology was invented and licensed from Rice University` and the dermatology applications were further developed with researchers from and the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth` Georgia